Cargando…
Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
The widely used lipid-lowering drug niacin was reported to increase blood glucose in diabetes. How does niacin regulate β Cell function in diabetic patients remains unclear. This study aimed to investigate the effect of niacin on β cell lipotoxicity in vitro and in vivo. Niacin treatment sensitized...
Autores principales: | Zhang, Xiaojing, Zhu, Baoyi, Lin, Peibin, Liu, Xiaoping, Gao, Jun, Yin, Dazhong, Zeng, Jianwen, Liao, Baojian, Kang, Zhanfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768175/ https://www.ncbi.nlm.nih.gov/pubmed/36568082 http://dx.doi.org/10.3389/fendo.2022.1057905 |
Ejemplares similares
-
Structural and Energetic Insights Into the Interaction of Niacin With the GPR109A Receptor
por: Adepu, Kiran Kumar, et al.
Publicado: (2021) -
Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
por: Giri, Banabihari, et al.
Publicado: (2019) -
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015) -
The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism
por: Geisler, Caroline E., et al.
Publicado: (2021) -
Upregulation of GPR109A in Parkinson’s Disease
por: Wakade, Chandramohan, et al.
Publicado: (2014)